Nature’s Toolbox Appoints Marcel Roche as Chief Financial Officer

Nature’s Toolbox Appoints Marcel Roche as Chief Financial Officer


Marcel Roche brings financial leadership experience from Illumina, Guardant Health, and Mission Bio

RIO RANCHO, N.M., October 03, 2023–(BUSINESS WIRE)–Nature’s Toolbox, Inc. (NTx), a life sciences company facilitating innovative RNA and protein research and manufacturing, today announced the expansion of its leadership team with the appointment of Marcel Roche as Chief Financial Officer. Marcel brings over 20 years of experience as a finance executive at both private and public life science and technology companies, including Illumina, Guardant Health, and Mission Bio.

This press release features multimedia. View the full release here:

NTx has appointed Marcel Roche as Chief Financial Officer to steer financial strategies and drive growth. (Photo: Business Wire)

During his tenure at Illumina, Marcel deployed the global financial planning practice and systems, led the DNA sequencing cost accounting team, and supported revenue growth from $70 million to over $1 billion. While at Guardant Health, he successfully built out the finance and accounting function, implemented company-wide enterprise resource planning (ERP) and managed Big 4 audits, leading up to an IPO. Most recently, Marcel served as CFO at Mission Bio where he was instrumental in equity financing and the negotiation of lab expansion efforts.

“I am thrilled to be joining a company that delivers a trifecta of seasoned leadership, highly differentiated technology, and multi-billion-dollar addressable markets,” said Marcel Roche. “NTx is uniquely positioned to revolutionize biomanufacturing by expanding access to life saving RNA and protein therapies. Additionally, NTx’s technology enables decentralized vaccine production, securing timely response to pandemics.”

“We are happy to welcome Marcel as the newest member of our leadership team. With a proven track record of financial acumen and strategic thinking, Marcel will play a pivotal role in steering our financial strategies and driving growth,” said Jamie Coffin, Ph.D., CEO of NTx. “We embrace innovation in our vaccine and therapeutic manufacturing capabilities and are confident that Marcel will bring fresh perspectives and financial expertise to help us achieve our strategic goals and enhance our financial performance. Marcel is an incredible addition to the NTx team, and I look forward to working with him closely.”

For more information about Nature’s Toolbox and its proprietary platform, please visit:

About NTx

Nature’s Toolbox, Inc. (NTx) is advancing the healthcare industry with their cutting-edge biomanufacturing solutions. NTx, based in Rio Rancho, New Mexico, is using innovative systems like NTxpress® and NTxscribe® to create life-saving medicines in an eco-friendly and sustainable way. Their proprietary biomanufacturing process uses hollow fiber bioreactors to support the increasing demand for mRNA-based vaccines and protein therapeutics. This easily scalable process enables NTx’s partners to increase production and streamline operations to meet changing global demands. To learn more about their game-changing approach, visit their website at

View source version on


Kalyn Kolek for NTx
[email protected]